These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6519850)

  • 1. Kinetics of penetration and clearance of mezlocillin in the bronchopulmonary tract.
    Braga PC; Marchi E; Scaglione F; Scarpazza G; Faravelli M; Fraschini F
    Int J Clin Pharmacol Res; 1984; 4(5):361-5. PubMed ID: 6519850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antimicrobial activity in comparison with tonsillar tissue penetration of mezlocillin.
    Martinetto P; Gariglio M; Cavallo GP; Malcangi A; Vitale M
    Chemioterapia; 1986 Dec; 5(6):385-7. PubMed ID: 3802299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experiences using acylureido-penicillins (azlocillin, mezlocillin) in pediatrics].
    Weingärtner L; Sitka U; Patsch R; Thiemann HH
    Klin Padiatr; 1984; 196(1):28-35. PubMed ID: 6694339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefoperazone pharmacokinetics and sputum levels after single/multiple i.m. injections in bronchopneumopathic patients and bone, pulmonary and prostatic tissue penetration.
    Braga PC; Scaglione F; Villa S; Scarpazza G; Gagliardi V; Biella G; Manganelli V; Paiola G; Fraschini F
    Int J Clin Pharmacol Res; 1983; 3(5):349-55. PubMed ID: 6678828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic therapy in biliary tract infections: clinical experiences with mezlocillin.
    Cristiano P; Iovene MR; Cioffi R; Salerno RA; Sicolo A; Cristinzio G; Paradisi F
    Chemioterapia; 1984 Jun; 3(3):178-82. PubMed ID: 6529774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory tract penetration of quinolone antimicrobials: a case in study.
    Ritrovato CA; Deeter RG
    Pharmacotherapy; 1991; 11(1):38-49. PubMed ID: 2020610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of infusion rate on pharmacokinetic parameters of azlocillin and mezlocillin].
    Haen E; Remien J; Richter E; Frank U; Adam D
    Arzneimittelforschung; 1985; 35(5):864-8. PubMed ID: 4026911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Penetration behavior of mezlocillin in chronic polypous inflamed mucosa of the paranasal sinuses].
    Thumfart W; Burkhardt F
    HNO; 1986 Apr; 34(4):170-4. PubMed ID: 3710846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Penetration of mezlocillin into bronchial secretions (author's transl)].
    Morel C; Benard Y; Vergnaud M; Langeard M
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):365-7. PubMed ID: 6460977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HPLC study of the pharmacokinetics of mezlocillin administered by 30-minute infusion and comparison with the direct intravenous route].
    Jehl F; Peter JD; Monteil H; Dupeyron JP; Minck R
    Pathol Biol (Paris); 1984 May; 32(5):312-7. PubMed ID: 6739140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciprofloxacin: multiple-dose pharmacokinetic and clinical results in patients with hypercrinic bronchopulmonary diseases.
    Fraschini F; Braga PC; Cosentina R; Salvini P; Cortelazzi R; Scarpazza G; Scaglione F; Trazzi R; Odero A
    Int J Clin Pharmacol Res; 1987; 7(1):63-71. PubMed ID: 3583489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of mezlocillin in patients with hepatobiliary dysfunction.
    Meyers BR; Srulevitch ES; Sacks HS; Hirschman SZ; Worner TM; Wormser GP; Jacobson J
    J Antimicrob Chemother; 1986 Dec; 18(6):709-13. PubMed ID: 3818496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of cefotaxime and penetration in sputum, bone, and prostatic tissue.
    Braga PC; Pozzato C; Cedrini C; Fraschini F; Scarpazza G; Scaglione F; Gagliardi V; Apicella F; Manganelli V; Paiola G
    Clin Ther; 1982; 5(1):69-78. PubMed ID: 6290066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetration of roxithromycin in bronchial secretions.
    De Rose V; Ferrara A; Mangiarotti P; Nonis A; Bertoletti R; Gialdroni Grassi G
    Int J Clin Pharmacol Res; 1988; 8(2):107-10. PubMed ID: 3378852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetic studies on the penetration of azlocillin and mezlocillin into bone and tissue fluid (author's transl)].
    Wittmann DH; Schassan HH; Seidel H
    Arzneimittelforschung; 1981; 31(7):1157-62. PubMed ID: 6456009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of mezlocillin in bronchial secretions (author's transl)].
    Bergogne-Berezin E; Pierre J; Even P; Reynaud P
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):361-4. PubMed ID: 6460976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental pharmacokinetics of mezlocillin in newborn infants.
    Janicke DM; Rubio TT; Wirth FH; Karotkin EH; Jusko WJ
    J Pediatr; 1984 May; 104(5):773-81. PubMed ID: 6716226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of seaprose on erythromycin penetration into bronchial mucus in bronchopulmonary infections.
    Braga PC; Piatti G; Grasselli G; Casali W; Beghi G; Allegra L
    Drugs Exp Clin Res; 1992; 18(3):105-11. PubMed ID: 1425205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tissue distribution of mezlocillin (author's transl)].
    Singlas E
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):373-6. PubMed ID: 6460979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative distribution of azithromycin in lung tissue of patients given oral daily doses of 500 and 1000 mg.
    Danesi R; Lupetti A; Barbara C; Ghelardi E; Chella A; Malizia T; Senesi S; Angeletti CA; Del Tacca M; Campa M
    J Antimicrob Chemother; 2003 Apr; 51(4):939-45. PubMed ID: 12654753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.